Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a J&J catheter.

The MAGiC catheter is designed to perform minimally invasive cardiac ablation procedures that treat various forms of ...

Stereotaxis has won FDA approval for the MAGiC Magnetic Interventional Ablation Catheter. The device is a robotically ...

Investing.com -- Stereotaxis (NYSE:STXS) stock surged 8.3% Tuesday after the surgical robotics company announced it received U.S. Food and Drug Administration (FDA) approval for its MAGiC Magnetic ...

CMS has approved electrophysiology ablation procedures for the ASC setting, marking a major advancement for outpatient cardiology and potentially accelerating the specialization of cardiac ASCs.

Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it obtained U.S.

Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...

Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, ...

Ramtha, Dec. 23 (Petra) – The King Abdullah University Hospital (KAUH) has performed its first catheter-based cardiac ablation procedures for the treatment of cardiac arrhythmias, using advanced ...

After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an international ...

The HRS and ACC released a scientific statement supporting the expansion of intracardiac ablation procedures to ambulatory surgical centers to improve patient access and operational efficiency. The ...

Paroxysmal supraventricular tachycardia (PSVT) is a common rapid arrhythmia observed in clinical settings, characterized by abrupt and sustained episodes lasting minutes to hours. It presents ...